Monsanto partnership

Bayer CropScience and Monsanto have entered into an exclusive agreement on a new fungicidal seed treatment for maize. The deal concerns Bayer's Vortex (ipconazole), which is expected to be commercialised in conjunction with the planned launch of Monsanto's multiple insect-resistant SmartStax maize in 2010 in the US. The deal is in line with Monsanto's plans to establish a global seed treatment business to complement its seed and trait operation (Agrow No 538, p 1)....

> Login for the full story
> Not a subscriber? Subscribe

RELATED NEWS

US approval for pyrosulfotole
Pioneer builds to Optimum GAT launch
Genetic modification aims to avoid ethical controversy